← Eichor
Condition: Mild Dementia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Mild Dementia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT04335994Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly
Phase N/A · 1 location(s) · Ludwig-Maximilians - University of Munich · NCT07504965Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia)
NA · 1 location(s) · Chung Shan Medical University · NCT06040905Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive
Phase N/A · 1 location(s) · Casa di Cura IGEA · NCT06701630Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Phase N/A · 1 location(s) · Alzheimer's Light LLC · NCT03657745OCT Angiography and NRAI in Dementia
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT03761381The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
NA · 1 location(s) · University of Washington · NCT06817122Tennessee Alzheimer's Project
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT05372172The Swedish BioFINDER - Memory Clinic Study
Phase N/A · 1 location(s) · Skane University Hospital · NCT06122415A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET
Phase 3 · 126 location(s) · Bristol-Myers Squibb · NCT06976203A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
Phase 2 · 1 location(s) · Johns Hopkins University · NCT04601038Cognitive Stimulation Therapy Group for Residential Home Residents With Dementia and Mild Cognitive Impairment
NA · 1 location(s) · City University of Hong Kong · NCT07372066Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of De
Phase 3 · 1 location(s) · Sichuan Jishengtang Pharmaceutical Co., Ltd. · NCT06534723Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
Phase 1/Phase 2 · 1 location(s) · University of California, Los Angeles · NCT06597942Optical Neuroimaging and Cognition
Phase N/A · 1 location(s) · University of Cambridge · NCT05460143Cognitive Screening Made Easy for PCPs - Administrative Supplement
NA · 3 location(s) · University of Texas at Austin · NCT06928298Early-Stage Partner in Care Living Alone Plus
NA · 1 location(s) · Arizona State University · NCT06962111Dementia With Lewy Bodies: Clinical Symptoms, Biomarkers and Progression
Phase N/A · 1 location(s) · Karolinska Institutet · NCT07629349TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
Phase 1 · 1 location(s) · University of California, San Diego · NCT06548191Stem Cell Therapy for Early Alzheimer's Disease
Phase 1/Phase 2 · 1 location(s) · Paul E Schulz · NCT06775964Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistic
NA · 1 location(s) · HudsonAlpha Institute for Biotechnology · NCT07146412GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
Phase 3 · 8 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07083154Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT04124029Novel Augmentation of DAOIB and Antioxidant for Early Dementia
Phase 2 · 1 location(s) · Chang Gung Memorial Hospital · NCT06467539A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease
Phase 3 · 1 location(s) · I.R.C.C.S. Fondazione Santa Lucia · NCT06702124Global Collaborative Research on Establishing a Korean Cognitive Aging Cohort
Phase N/A · 1 location(s) · Korea University · NCT07485387A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Phase 1 · 10 location(s) · Eli Lilly and Company · NCT06297590ADRC Clinical Cohort (Alzheimer's Disease)
Phase N/A · 1 location(s) · Duke University · NCT06703541A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 3 · 143 location(s) · Hoffmann-La Roche · NCT07169578
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.